Patients Support Program

At AuroCare, empathy is our foundation, excellence is our standard, and meaningful care is the impact we deliver.

Auro-Nintedanib

Auro-Nintedanib is indicated for the treatment of Idiopathic Pulmonary Fibrosis (IPF), Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD), and other chronic fibrosing interstitial lung diseases. Canadian reference product OFEV®.

Patients Support Program

At AuroCare, empathy is our foundation, excellence is our standard, and meaningful care is the impact we deliver.

Auro-Nintedanib

Every conversation begins with understanding, every step reflects expertise, and every outcome elevates patient well-being.

*Subject to provincial regulations. Co-Pay support and financial support through AuroCare™ is not available to Quebec residents.

Coming

Soon